Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Siegal, GP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hemminki, A; Belousova, N; Zinn, KR; Liu, B; Wang, MH; Chaudhuri, TR; Rogers, BE; Buchsbaum, DJ; Siegal, GP; Barnes, MN; Gomez-Navarro, J; Curiel, DT; Alvarez, RD
      An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression

      MOLECULAR THERAPY
    2. Casado, E; Gomez-Navarro, J; Yamamoto, M; Adachi, Y; Coolidge, CJ; Arafat, WO; Barker, SD; Wang, MH; Mahasreshti, PJ; Hemminki, A; Gonzalez-Baron, M; Barnes, MN; Pustilnik, TB; Siegal, GP; Alvarez, RD; Curiel, DT
      Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications

      CLINICAL CANCER RESEARCH
    3. Mahasreshti, PJ; Navarro, JG; Kataram, M; Wang, MH; Carey, D; Siegal, GP; Barnes, MN; Nettelbeck, DM; Alvarez, RD; Hemminki, A; Curiel, DT
      Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma

      CLINICAL CANCER RESEARCH
    4. Ferguson, WS; Harris, MB; Goorin, AM; Gebhardt, MC; Link, MP; Shochat, SJ; Siegal, GP; Devidas, M; Grier, HE
      Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    5. Listinsky, JJ; Listinsky, CM; Alapati, V; Siegal, GP
      Cell surface fucose ablation as a therapeutic strategy for malignant neoplasms

      ADVANCES IN ANATOMIC PATHOLOGY
    6. Hamza, S; Anderson, P; Reddy, VVB; Siegal, GP
      Use of the Internet in pathology resident training and education

      ADVANCES IN ANATOMIC PATHOLOGY
    7. Vigneswaran, N; Fernandes, R; Rodu, B; Baughman, RA; Siegal, GP
      Aggressive osteoblastoma of the mandible closely simulating calcifying epithelial odontogenic tumor - Report of two cases with unusual histopathologic findings

      PATHOLOGY RESEARCH AND PRACTICE
    8. Siegal, GP
      Osteochondromyxoma of bone - A lot more than fodder for the spelling-challenged

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    9. Casado, E; Nettelbeck, DM; Gomez-Navarro, J; Hemminki, A; Baron, MG; Siegal, GP; Barnes, MN; Alvarez, RD; Curiel, DT
      Transcriptional targeting for ovarian cancer gene therapy

      GYNECOLOGIC ONCOLOGY
    10. Barker, SD; Casado, E; Gomez-Navarro, J; Xiang, J; Arafat, W; Mahasreshti, P; Pustilnik, TB; Hemminki, A; Siegal, GP; Alvarez, RD; Curiel, DT
      An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites

      GYNECOLOGIC ONCOLOGY
    11. Cusmariu, JR; Lopez-Ben, R; Siegal, GP; Jaffe, K
      Enlarging toe mass in a 13-year-old girl

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    12. Cherry, P; Lopez-Ben, R; Jaffe, KA; Siegal, GP
      Paraspinal mass in a 14-year-old girl

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    13. Ponnazhagan, S; Curiel, DT; Shaw, DR; Alvarez, RD; Siegal, GP
      Adeno-associated virus for cancer gene therapy

      CANCER RESEARCH
    14. Steinhauer, JR; Moran, CA; Siegal, GP
      Pathologic quiz case - An asymptomatic patient with a large renal mass

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    15. Alvarez, RD; Gomez-Navarro, J; Wang, MH; Barnes, MN; Strong, TV; Arani, RB; Arafat, W; Hughes, JV; Siegal, GP; Curiel, DT
      Adenoviral-mediated suicide gene therapy for ovarian cancer

      MOLECULAR THERAPY
    16. Arafat, WO; Gomez-Navarro, J; Xiang, JL; Barnes, MN; Mahasreshti, P; Alvarez, RD; Siegal, GP; Badib, AO; Buchsbaum, D; Curiel, DT; Stackhouse, MA
      An adenovirus encoding proapoptotic Bax induces apoptosis and enhances theradiation effect in human ovarian cancer

      MOLECULAR THERAPY
    17. Rosado, KE; Pitt, MJ; Siegal, GP
      Osteoblastoma: A mimic of osteosarcoma

      PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    18. Xiang, J; Gomez-Navarro, J; Arafat, W; Liu, B; Barker, SD; Alvarez, RD; Siegal, GP; Curiel, DT
      Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer

      JOURNAL OF GENE MEDICINE
    19. Alvarez, RD; Barnes, MN; Gomez-Navarro, J; Wang, MH; Strong, TV; Arafat, W; Arani, RB; Johnson, MR; Roberts, BL; Siegal, GP; Curiel, DT
      A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial

      CLINICAL CANCER RESEARCH
    20. Arafat, WO; Casado, E; Wang, M; Alvarez, RD; Siegal, GP; Glorioso, JC; Curiel, DT; Gomez-Navarro, J
      Genetically modified CD34(+) cells exert a cytotoxic bystander effect on human endothelial and cancer cells

      CLINICAL CANCER RESEARCH
    21. Arafat, W; Gomez-Navarro, J; Xiang, JL; Siegal, GP; Alvarez, RD; Curiel, DT
      Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFvaffinity for its target

      CANCER GENE THERAPY
    22. Winokur, TS; McClellan, S; Siegal, GP; Redden, D; Gore, P; Lazenby, A; Reddy, V; Listinsky, CM; Conner, DA; Goldman, J; Grimes, G; Vaughn, G; McDonald, JM
      Prospective trial of telepathology for intraoperative consultation (Frozensections)

      HUMAN PATHOLOGY
    23. Deshane, J; Alvarez, RD; Siegal, GP
      Eradication of c-erbB-2-positive ovarian cancer cells mediated by intracellular expression of anti-c-erbB-2 antibody

      OVARIAN CANCER: METHODS AND PROTOCOLS
    24. Xiang, J; Piche, A; Rancourt, C; Gomez-Navarro, J; Siegal, GP; Alvarez, RD; Curiel, DT
      An inducible recombinant adenoviral vector encoding Bax selectively induces apoptosis in ovarian cancer cells

      TUMOR TARGETING
    25. Khuu, H; Conner, M; Vanderkwaak, T; Shultz, J; Gomez-Navarro, J; Alvarez, RD; Curiel, DT; Siegal, GP
      Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    26. Lopez-Ben, R; Pitt, MJ; Jaffe, KA; Siegal, GP
      Osteosarcoma in a patient with McCune-Albright syndrome and Mazabrand's syndrome

      SKELETAL RADIOLOGY
    27. Vanderkwaak, TJ; Wang, MH; Gomez-Navarro, J; Rancourt, C; Dmitriev, I; Krasnykh, V; Barnes, M; Siegal, GP; Alvarez, R; Curiel, DT
      An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

      GYNECOLOGIC ONCOLOGY
    28. Jaffe, KA; Pham, DH; Chivers, FS; Siegal, GP
      Pathologic femoral fracture in a 76-year-old woman - Dedifferentiated chondrosarcoma.

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    29. Pan, G; Vickers, SM; Pickens, A; Phillips, JO; Ying, WZ; Thompson, JA; Siegal, GP; McDonald, JM
      Apoptosis and tumorigenesis in human cholangiocarcinoma cells involvement of Fas/APO-1 (CD95) and calmodulin

      AMERICAN JOURNAL OF PATHOLOGY
    30. RANCOURT C; ROBERTSON MW; WANG MH; GOLDMAN CK; KELLY JF; ALVAREZ RD; SIEGAL GP; CURIEL DT
      ENDOTHELIAL-CELL VEHICLES FOR DELIVERY OF CYTOTOXIC GENES AS A GENE-THERAPY APPROACH FOR CARCINOMA OF THE OVARY

      Clinical cancer research
    31. RANCOURT C; ROBERTSON MW; WANG MH; GOLDMAN CK; KELLY JF; ALVAREZ RD; SIEGAL GP; CURIEL DT
      ENDOTHELIAL-CELL VEHICLES FOR DELIVERY OF CYTOTOXIC GENES AS A GENE-THERAPY APPROACH FOR CARCINOMA OF THE OVARY

      Clinical cancer research
    32. RANCOURT C; ROGERS BE; SOSNOWSKI BA; WANG MH; PICHE A; PIERCE GF; ALVAREZ RD; SIEGAL GP; DOUGLAS JT; CURIEL DT
      BASIC FIBROBLAST-GROWTH-FACTOR ENHANCEMENT OF ADENOVIRUS-MEDIATED DELIVERY OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE RESULTS IN AUGMENTED THERAPEUTIC BENEFIT IN A MURINE MODEL OF OVARIAN-CANCER

      Clinical cancer research
    33. GRIM J; DESHANE J; SIEGAL GP; ALVAREZ RD; DIFIORE P; CURIEL DT
      THE LEVEL OF ERBB2 EXPRESSION PREDICTS SENSITIVITY TO THE CYTOTOXIC EFFECTS OF AN INTRACELLULAR ANTI-ERBB2 SFV

      Journal of molecular medicine
    34. ROBERTSON MW; WANG MH; SIEGAL GP; ROSENFELD M; ASHFORD RS; ALVAREZ RD; GARVER RI; CURIEL DT
      USE OF A TISSUE-SPECIFIC PROMOTER FOR TARGETED EXPRESSION OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE IN CERVICAL-CARCINOMA CELLS

      Cancer gene therapy
    35. ROBERTSON MW; BARNES MN; RANCOURT C; WANG MH; GRIM J; ALVAREZ RD; SIEGAL GP; CURIEL DT
      GENE-THERAPY FOR OVARIAN-CARCINOMA

      Seminars in oncology
    36. Wang, MH; Rancourt, C; Navarro, JG; Krisky, D; Marconi, P; Oligino, T; Alvarez, RD; Siegal, GP; Glorioso, JC; Curiel, DT
      High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector

      GYNECOLOGIC ONCOLOGY
    37. GOLDMAN CK; KENDALL RL; CABRERA G; SOROCEANU L; HEIKE Y; GILLESPIE GY; SIEGAL GP; MAO XZ; BETT AJ; HUCKLE WR; THOMAS KA; CURIEL DT
      PARACRINE EXPRESSION OF A NATIVE SOLUBLE VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR INHIBITS TUMOR-GROWTH, METASTASIS, AND MORTALITY-RATE

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. AVERYT J; CHIVERS FS; JAFFE KA; SIEGAL GP
      SHOULDER MASS IN A 38-YEAR-OLD WOMAN

      Clinical orthopaedics and related research
    39. WANGJOHANNING F; GILLESPIE GY; GRIM J; RANCOURT C; ALVAREZ RD; SIEGAL GP; CURIEL DT
      INTRACELLULAR EXPRESSION OF A SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST HUMAN-PAPILLOMAVIRUS TYPE-16 E7 ONCOPROTEIN ACHIEVES TARGETED ANTINEOPLASTIC EFFECTS

      Cancer research
    40. GRIM JE; SIEGAL GP; ALVAREZ RD; CURIEL DT
      INTRACELLULAR EXPRESSION OF THE ANTI-ERBB-2 SFV N29 FAILS TO ACCOMPLISH EFFICIENT TARGET MODULATION

      Biochemical and biophysical research communications (Print)
    41. LISTINSKY JJ; SIEGAL GP; LISTINSKY CM
      ALPHA-L-FUCOSE - A POTENTIALLY CRITICAL MOLECULE IN PATHOLOGICAL PROCESSES INCLUDING NEOPLASIA

      AJCP. American journal of clinical pathology
    42. WINOKUR TS; MCCLELLAN S; SIEGAL GP; REDDY V; LISTINSKY CM; CONNER D; GOLDMAN J; GRIMES G; VAUGHN G; MCDONALD JM
      AN INITIAL TRIAL OF A PROTOTYPE TELEPATHOLOGY SYSTEM FEATURING STATICIMAGING WITH DISCRETE CONTROL OF THE REMOTE MICROSCOPE

      AJCP. American journal of clinical pathology
    43. SCHWARTZ GG; WANG MH; ZHANG M; SINGH RK; SIEGAL GP
      1-ALPHA,25-DIHYDROXYVITAMIN-D (CALCITRIOL) INHIBITS THE INVASIVENESS OF HUMAN PROSTATE-CANCER CELLS

      Cancer epidemiology, biomarkers & prevention
    44. WRIGHT M; GRIM J; DESHANE J; KIM M; STRONG TV; SIEGAL GP; CURIEL DT
      AN INTRACELLULAR ANTI-ERBB-2 SINGLE-CHAIN ANTIBODY IS SPECIFICALLY CYTOTOXIC TO HUMAN BREAST-CARCINOMA CELLS OVEREXPRESSING ERBB-2

      Gene therapy
    45. PICHE A; GRIM J; RANCOURT C; GOMEZNAVARRO J; ALVAREZ R; SIEGAL GP; CURIEL DT
      CHEMOSENSITIZATION OF OVARIAN-CANCER CELLS MEDIATED BY INTRACELLULAR EXPRESSION OF AN ANTI-BCL-2 SINGLE-CHAIN ANTIBODY

      Cancer gene therapy
    46. WANG MH; RANCOURT C; ALVAREZ RD; SIEGAL GP; GLORIOSO JC; CURIEL DT
      HIGH EFFICACY OF THYMIDINE KINASE GENE-TRANSFER TO OVARIAN-CANCER CELL-LINES MEDIATED BY HERPES-SIMPLEX VIRUS TYPE-1 VECTOR

      Cancer gene therapy
    47. RANCOURT C; ROBERTSON MW; WANG MH; ALVAREZ RD; SIEGAL GP; CURIEL DT
      HUMAN ENDOTHELIAL-CELLS AS CELLULAR VEHICLES FOR OVARIAN-CANCER GENE-THERAPY

      Cancer gene therapy
    48. FENG M; JACKSON WH; RANCOURT C; SIEGAL GP; GILLESPIE GY; CURIEL DT
      STABLE IN-VIVO GENE TRANSDUCTION VIA A NOVEL ADENOVIRAL RETROVIRAL CHIMERIC VECTOR/

      Cancer gene therapy
    49. RANCOURT C; WANG MH; ALVAREZ RD; SIEGAL GP; FULLER G; CURIEL DT
      IL-6 MODULATED CONDITIONALLY REPLICATIVE ADENOVIRUS FOR GENE-THERAPY OF SOLID TUMORS

      Cancer gene therapy
    50. RANCOURT C; WANG MH; ALVAREZ RD; SIEGAL GP; FULLER G; CURIEL DT
      CONDITIONALLY REPLICATIVE ADENOVIRUS FOR CANCER GENE-THERAPY

      Cancer gene therapy
    51. RANCOURT C; ROBERSTON MW; WANG MH; ALVAREZ RD; SIEGAL GP; CURIEL DT
      HUMAN ENDOTHELIAL-CELLS AS CELLULAR VEHICLES FOR OVARIAN-CANCER GENE-THERAPY

      Cancer gene therapy
    52. ZHANG M; SINGH RK; KRASNYKH V; WELLS A; GOPURALA B; SIEGAL GP
      AN EGF REGULATORY ELEMENT IS REQUIRED FOR EGF-INDUCED CD44 GENE-EXPRESSION

      The FASEB journal
    53. DESHANE J; SIEGAL GP; WANG MH; WRIGHT M; BUCY RP; ALVAREZ RD; CURIEL DT
      TRANSDUCTIONAL EFFICACY AND SAFETY OF AN INTRAPERITONEALLY DELIVERED ADENOVIRUS ENCODING AN ANTI-ERBB-2 INTRACELLULAR SINGLE-CHAIN ANTIBODYFOR OVARIAN-CANCER GENE-THERAPY

      Gynecologic oncology
    54. BARNES MN; DESHANE JS; ROSENFELD M; SIEGAL GP; CURIEL DT; ALVAREZ RD
      GENE-THERAPY AND OVARIAN-CANCER - A REVIEW

      Obstetrics and gynecology
    55. ZHANG M; WANG MH; SINGH RK; WELLS A; SIEGAL GP
      EPIDERMAL GROWTH-FACTOR INDUCES CD44 GENE-EXPRESSION THROUGH A NOVEL REGULATORY ELEMENT IN MOUSE FIBROBLASTS

      The Journal of biological chemistry
    56. GOLDMAN CK; ROGERS BE; DOUGLAS JT; SOSNOWSKI BA; YING WB; SIEGAL GP; BAIRD A; CAMPAIN JA; CURIEL DT
      TARGETED GENE DELIVERY TO KAPOSIS-SARCOMA CELLS VIA THE FIBROBLAST GROWTH-FACTOR RECEPTOR

      Cancer research
    57. BARNES MN; DESHANE JS; SIEGAL GP; ALVAREZ RD; CURIEL DT
      NOVEL GENE-THERAPY STRATEGY TO ACCOMPLISH GROWTH-FACTOR MODULATION INDUCES ENHANCED TUMOR-CELL CHEMOSENSITIVITY

      Clinical cancer research
    58. ROSENFELD ME; WANG M; SIEGAL GP; ALVAREZ RD; MIKHEEVA G; KRASNYKH V; CURIEL DT
      ADENOVIRAL-MEDIATED DELIVERY OF HERPES-SIMPLEX VIRUS THYMIDINE KINASERESULTS IN TUMOR REDUCTION AND PROLONGED SURVIVAL IN A SCID MOUSE MODEL OF HUMAN OVARIAN-CARCINOMA

      Journal of molecular medicine
    59. DESHANE J; GRIM J; LOECHEL S; SIEGAL GP; ALVAREZ RD; CURIEL DT
      INTRACELLULAR ANTIBODY AGAINST ERBB-2 MEDIATES TARGETED TUMOR-CELL ERADICATION BY APOPTOSIS

      Cancer gene therapy
    60. SINGH RK; RINEHART CA; KIM JP; TOLLESONRINEHART S; LAWING LF; KAUFMAN DG; SIEGAL GP
      TUMOR-CELL INVASION OF BASEMENT-MEMBRANE IN-VITRO IS REGULATED BY AMINO-ACIDS

      Cancer investigation
    61. ZHANG M; SINGH RK; WANG MH; WELLS A; SIEGAL GP
      EPIDERMAL GROWTH-FACTOR MODULATES CELL ATTACHMENT TO HYALURONIC-ACID BY THE CELL-SURFACE GLYCOPROTEIN CD44

      Clinical & experimental metastasis
    62. TAGOURI YM; SANDERS PW; PICKEN MM; SIEGAL GP; KERBY JD; HERRERA GA
      IN-VITRO AL-AMYLOID FORMATION BY RAT AND HUMAN MESANGIAL CELLS

      Laboratory investigation
    63. SIEGAL GP; WANG MH; LAMPEJO O; LAWING L; ZHANG M; SINGH RK; SCHWARTZ GG
      THE INVASIVE PHENOTYPE CAN BE SEPARATED IN-VITRO FROM THE ANTIPROLIFERATIVE EFFECT OF VITAMIN-D IN PROSTATIC ADENOCARCINOMA CELLS

      Laboratory investigation
    64. LISTINSKY JJ; LISTINSKY CM; MYERS RB; GRIZZLE WE; DEMUTH PA; LAWING LF; SIEGAL GP
      ALPHA-FUCOSIDASE REDUCES THE INVASIVENESS OF DU-145 PROSTATE CARCINOMA-CELLS IN-VITRO

      Laboratory investigation
    65. ROSENFELD ME; SIEGAL GP; ALVAREZ RD; WANG MH; CURIEL DT
      ADENOVIRAL MEDIATED DELIVERY OF HSVTK RESULTS IN REDUCED TUMOR BURDENIN SCID MICE XENOGRAFTED WITH HUMAN OVARIAN-CARCINOMA CELLS AND TREATED WITH GANCICLOVIR

      Laboratory investigation
    66. ROSENFELD ME; FENG MZ; MICHAEL SI; SIEGAL GP; ALVAREZ RD; CURIEL DT
      ADENOVIRAL-MEDIATED DELIVERY OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE SELECTIVELY SENSITIZES HUMAN OVARIAN-CARCINOMA CELLS TO GANCICLOVIR

      Clinical cancer research
    67. JAFFE KA; WADE JD; CHIVERS FS; SIEGAL GP
      EXTRASKELETAL OSTEOSARCOMA - AN UNUSUAL PRESENTATION AS TARSAL TUNNEL-SYNDROME

      Foot & ankle international
    68. LOGAN JJ; BEBOK Z; WALKER LC; PENG SY; FELGNER PL; SIEGAL GP; FRIZZELL RA; DONG JY; HOWARD M; MATALON S; LINDSEY JR; DUVALL M; SORSCHER EJ
      CATIONIC LIPIDS FOR REPORTER GENE AND CFTR TRANSFER TO RAT PULMONARY EPITHELIUM

      Gene therapy
    69. BASS C; CABRERA G; ELGAVISH A; ROBERT B; SIEGAL GP; ANDERSON SC; MANEVAL DC; CURIEL DT
      RECOMBINANT ADENOVIRUS-MEDIATED GENE-TRANSFER TO GENITOURINARY EPITHELIUM IN-VITRO AND IN-VIVO

      Cancer gene therapy
    70. XIE H; WANG MH; SINGH RK; SIEGAL GP; WELLS A
      IN-VITRO INVASIVENESS OF DU-145 PROSTATE CARCINOMA-CELLS IS MODULATEDBY EGF RECEPTOR-MEDIATED SIGNALS

      The FASEB journal
    71. SINGH RK; LAWING LF; WANG MH; SIEGAL GP
      INDUCIBLE AMINO-ACID TRANSPORTERS MODULATE HUMAN TUMOR-CELL GROWTH AND INVASION

      The FASEB journal
    72. ROBINSON LH; PITT MJ; JAFFE KA; SIEGAL GP
      SMALL-CELL OSTEOSARCOMA OF THE SOFT-TISSUE

      Skeletal radiology
    73. SINGH RK; SIEGAL GP
      AMINO-ACID-TRANSPORT SYSTEMS MODULATE HUMAN TUMOR-CELL GROWTH AND INVASION - A WORKING HYPOTHESIS

      Medical hypotheses
    74. XIE H; TURNER T; WANG MH; SINGH RK; SIEGAL GP; WELLS A
      IN-VITRO INVASIVENESS OF DU-145 HUMAN PROSTATE CARCINOMA-CELLS IS MODULATED BY EGF RECEPTOR-MEDIATED SIGNALS

      Clinical & experimental metastasis
    75. SINGH RK; HARDY RW; WANG MH; WILLIFORD J; GLADSON CL; MCDONALD JM; SIEGAL GP
      STEARATE INHIBITS HUMAN TUMOR-CELL INVASION

      Invasion & metastasis
    76. DESHANE J; CABRERA G; GRIM JE; SIEGAL GP; PIKE J; ALVAREZ RD; CURIEL DT
      TARGETED ERADICATION OF OVARIAN-CANCER MEDIATED BY INTRACELLULAR EXPRESSION OF ANTI-ERBB-2 SINGLE-CHAIN ANTIBODY

      Gynecologic oncology
    77. TAGOURI Y; SANDERS PW; PICKEN MM; SIEGAL GP; HERRERA GA
      IN-VITRO AL-AMYLOID FORMATION BY MESANGIAL CELLS

      Laboratory investigation
    78. HELSETH A; HAUG E; NESLAND JM; SIEGAL GP; FODSTAD O; BAUTCH VL
      ENDOCRINE AND METABOLIC CHARACTERISTICS OF POLYOMA LARGE-T TRANSGENICMICE THAT DEVELOP ACTH-PRODUCING PITUITARY-TUMORS

      Journal of neurosurgery
    79. DESHANE J; SIEGAL GP; ALVAREZ RD; WANG MH; FENG MZ; CABRERA G; LIU TP; KAY M; CURIEL DT
      TARGETED TUMOR KILLING VIA AN INTRACELLULAR ANTIBODY AGAINST ERBB-2

      The Journal of clinical investigation
    80. BERRY KK; SIEGAL GP; BOYD JA; SINGH RK; FIDLER IJ
      DEVELOPMENT OF A METASTATIC MODEL FOR HUMAN ENDOMETRIAL CARCINOMA USING ORTHOTOPIC IMPLANTATION IN NUDE-MICE

      International journal of oncology
    81. GOODLY LJ; SINGH RK; WANG MH; SIEGAL GP
      IN-VIVO MODULATION OF HUMAN TUMOR-CELL GROWTH BY NORMAL HUMAN EXTRACELLULAR-MATRIX

      Tumor biology
    82. DESHANE J; LOECHEL F; CONRY RM; SIEGAL GP; KING CR; CURIEL DT
      INTRACELLULAR SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST ERBB2 DOWN-REGULATES CELL-SURFACE ERBB2 AND EXHIBITS A SELECTIVE ANTIPROLIFERATIVE EFFECT IN ERBB2 OVEREXPRESSING CANCER CELL-LINES

      Gene therapy
    83. WANG R; SIEGAL GP; SCOTT DL; BAUTCH VL
      DEVELOPMENTAL ANALYSIS OF BONE-TUMORS IN POLYOMAVIRUS TRANSGENIC MICE

      Laboratory investigation
    84. ROBINSON LH; UNNI KK; OLAUGHLIN S; BEABOUT JW; SIEGAL GP
      SURFACE CHONDROMYXOID FIBROMA OF BONE

      Laboratory investigation
    85. LISTINSKY CM; SIEGAL GP; WANG MH; DEMUTH PA; SAKAI TT; LISTINSKY JJ
      MOBILE FUCOLIPID CONTENT IN THE MEMBRANES OF NEOPLASTIC-CELLS - A POTENTIAL PROGNOSTIC MARKER MEASURED BY H-1-NMR SPECTROSCOPY

      Laboratory investigation
    86. VOLLMER G; LIGHTNER VA; CARTER CA; SIEGAL GP; ERICKSON HP; KNUPPEN R; KAUFMAN DG
      LOCALIZATION OF TENASCIN IN UTERINE SARCOMAS AND PARTIALLY TRANSFORMED ENDOMETRIAL STROMAL CELLS

      Pathobiology
    87. SIEGAL GP; WANG MH; RINEHART CA; KENNEDY JW; GOODLY LJ; MILLER Y; KAUFMAN DG; SINGH RK
      DEVELOPMENT OF A NOVEL HUMAN EXTRACELLULAR-MATRIX FOR QUANTITATION OFTHE INVASIVENESS OF HUMAN-CELLS

      Cancer letters
    88. SASAKI H; NISHII H; TAKAHASHI H; TADA A; FURUSATO M; TERASHIMA Y; SIEGAL GP; PARKER SL; KOHLER MF; BERCHUCK A; BOYD J
      MUTATION OF THE KI-RAS PROTOONCOGENE IN HUMAN ENDOMETRIAL HYPERPLASIAAND CARCINOMA

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/07/20 alle ore 22:25:22